These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 21497980)

  • 1. [On the metabolism of prasugrel].
    Barrera-Ramírez CF; Pineda-Pompa LR; Guzmán-Rodríguez CE
    Rev Esp Cardiol; 2011 Jul; 64(7):629. PubMed ID: 21497980
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of CYP2C19 gene polymorphisms on the pharmacokinetics and pharmacodynamics of prasugrel 5-mg, prasugrel 10-mg and clopidogrel 75-mg in patients with coronary artery disease.
    Gurbel PA; Bergmeijer TO; Tantry US; ten Berg JM; Angiolillo DJ; James S; Lindahl TL; Svensson P; Jakubowski JA; Brown PB; Duvvuru S; Sundseth S; Walker JR; Small D; Moser BA; Winters KJ; Erlinge D
    Thromb Haemost; 2014 Sep; 112(3):589-97. PubMed ID: 25008027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary artery calcification is not related to coronary heart disease isolated family history.
    Koulaouzidis G; Wong K; Charisopoulou D; McArthur T; Jenkins PJ; Henein MY
    Int J Cardiol; 2015; 190():271-2. PubMed ID: 25932803
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacodynamic effects of standard dose prasugrel versus high dose clopidogrel in non-diabetic obese patients with coronary artery disease.
    Darlington A; Tello-Montoliu A; Rollini F; Ueno M; Ferreiro JL; Patel R; Desai B; Guzman LA; Bass TA; Angiolillo DJ
    Thromb Haemost; 2014 Feb; 111(2):258-65. PubMed ID: 24154863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of plasma miR-223 and platelet reactivity in patients with coronary artery disease on dual antiplatelet therapy: A preliminary report.
    Chyrchel B; Totoń-Żurańska J; Kruszelnicka O; Chyrchel M; Mielecki W; Kołton-Wróż M; Wołkow P; Surdacki A
    Platelets; 2015; 26(6):593-7. PubMed ID: 25350775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study on the impact of CYP2C19 genotype and platelet reactivity assay on patients undergoing PCI.
    Rath PC; Chidambaram S; Rath P; Dikshit B; Naik S; Sahoo PK; Das B; Mahalingam M; Khandrika L; Jain J
    Indian Heart J; 2015; 67(2):114-21. PubMed ID: 26071289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional Signatures, Imaging, and Coronary Artery Disease Diagnosis.
    Rosenberg S
    J Cardiovasc Transl Res; 2015 Jul; 8(5):279-80. PubMed ID: 25968136
    [No Abstract]   [Full Text] [Related]  

  • 8. Parental history as a independent risk factor of coronary heart disease in patients under 60 years of age.
    Scardi S
    Monaldi Arch Chest Dis; 2008 Jun; 70(2):88-9. PubMed ID: 18754277
    [No Abstract]   [Full Text] [Related]  

  • 9. Increased platelet inhibition after switching from maintenance clopidogrel to prasugrel in Japanese patients with stable coronary artery disease.
    Nishi T; Ariyoshi N; Nakayama T; Fujimoto Y; Sugimoto K; Takahara M; Wakabayashi S; Koshizaka M; Hanaoka H; Kobayashi Y
    Circ J; 2015; 79(11):2439-44. PubMed ID: 26310876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced active metabolite generation and platelet inhibition with prasugrel compared to clopidogrel regardless of genotype in thienopyridine metabolic pathways.
    Braun OÖ; Angiolillo DJ; Ferreiro JL; Jakubowski JA; Winters KJ; Effron MB; Duvvuru S; Costigan TM; Sundseth S; Walker JR; Saucedo JF; Kleiman NS; Varenhorst C
    Thromb Haemost; 2013 Dec; 110(6):1223-31. PubMed ID: 24009042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prasugrel in Clopidogrel Nonresponders Undergoing Percutaneous Coronary Intervention: The RECLOSE-3 Study (REsponsiveness to CLOpidogrel and StEnt Thrombosis).
    Valenti R; Marcucci R; Comito V; Marrani M; Cantini G; Migliorini A; Parodi G; Gensini GF; Abbate R; Antoniucci D
    JACC Cardiovasc Interv; 2015 Oct; 8(12):1563-70. PubMed ID: 26386764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Switching From Prasugrel to Clopidogrel Shortly After a Percutaneous Coronary Intervention Without a Loading Dose of Clopidogrel.
    Mizrahi E; Suryadevara RS; Barn K; Boga G; Akram MM; Ismail-Sayed I; Henry YM; Troup MA; Berger PB
    J Invasive Cardiol; 2015 Dec; 27(12):543-6. PubMed ID: 26378415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decoding coronary artery disease: somatic mosaicism and genomics for personal and population risk prediction.
    Katsouras CS; Baltogiannis GG; Naka KK; Roukos DH; Michalis LK
    Biomark Med; 2013 Apr; 7(2):189-92. PubMed ID: 23547811
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytochrome P450 2B6 and 2C9 genotype polymorphism--a possible cause of prasugrel low responsiveness.
    Franken CC; Kaiser AF; Krüger JC; Overbeck K; Mügge A; Neubauer H
    Thromb Haemost; 2013 Jul; 110(1):131-40. PubMed ID: 23615745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Game theory and microarray analysis in coronary artery disease and atherosclerosis: Math helps the cardiology research.
    Zuin M; Rigatelli G; Picariello C; Badin M; Badin A; Zuliani G; Faggian G; Roncon L
    Int J Cardiol; 2016 Jul; 215():143-4. PubMed ID: 27111179
    [No Abstract]   [Full Text] [Related]  

  • 16. Gene expression algorithm for prevalent coronary artery disease: a first step in a long journey.
    Arnett DK
    Ann Intern Med; 2010 Oct; 153(7):473-4. PubMed ID: 20921546
    [No Abstract]   [Full Text] [Related]  

  • 17. Bibliography--editors' selection of current world literature.
    Coron Artery Dis; 2007 Nov; 18(7):589-94. PubMed ID: 17925615
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacodynamic effects of cangrelor on platelet P2Y12 receptor-mediated signaling in prasugrel-treated patients.
    Rollini F; Franchi F; Tello-Montoliu A; Patel R; Darlington A; Ferreiro JL; Cho JR; Muñiz-Lozano A; Desai B; Zenni MM; Guzman LA; Bass TA; Angiolillo DJ
    JACC Cardiovasc Interv; 2014 Apr; 7(4):426-34. PubMed ID: 24630878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene Expression Signatures and the Spectrum of Coronary Artery Disease.
    Friede KA; Ginsburg GS; Voora D
    J Cardiovasc Transl Res; 2015 Aug; 8(6):339-52. PubMed ID: 26089288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bibliography-editors' selection of current world literature.
    Coron Artery Dis; 2008 Aug; 19(5):371-3. PubMed ID: 18607175
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.